Humacyte

HUMA NASDAQ
Overview Stats Financials News

Quarterly Financials

Values in thousands 2024-03-31 2023-12-31 2023-09-30 2023-06-30
Revenue $0 $10,790 $0 $0
Gross Profit -1,791 7,412 -1,315 -1,995
EBITDA -24,787 -22,804 -21,423 -20,162
EBIT -26,578 -26,182 -23,253 -22,145
Net Income -31,896 -25,106 -25,995 -22,706
Net Change In Cash 0 10,790 0 0
Cost of Revenue -14,966
Free Cash Flow -27,738 -19,204 -13,500 -23,088
Cash 115,505 80,592 99,986 114,604
Basic Shares 108,246 103,607 103,444 103,361

Annual Financials

Values in thousands 2023-12-31 2022-12-31 2021-12-31 2020-12-31
Revenue $0 $1,565 $1,263 $1,491
Gross Profit -7,719 -6,690 1,214 -6,941
EBITDA -92,328 -160,345 -136,980 -55,971
EBIT -100,047 -84,578 -81,208 -64,600
Net Income -110,776 64,219 37,536 -68,726
Net Change In Cash 0 1,565 1,263 1,491
Cost of Revenue -67,730 177,573
Free Cash Flow -75,585 -72,177 -81,410 -55,886
Cash 80,592 149,772 217,502 39,929
Basic Shares 103,420 103,051 39,970 5,822

Earnings Calls

Quarter EPS
2024-03-31 -$0.29
2023-12-31 -$0.24
2023-09-30 -$0.25
2023-06-30 -$0.22